Stock Fundamentals

Company Information

Company Name
Regulus Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US75915K3095
CIK: 0001505512
CUSIP: 75915K200
Currency: USD
Full Time Employees: 34
Phone: 858 202 6300
Fiscal Year End: December
IPO Date: Oct 04, 2012
Description:

Regulus Therapeutics Inc. engages in the development of drugs designed to inhibit dysregulated microRNA targets for the benefit of patients with genetically based orphan diseases. The company develops farabursen, an anti-miR oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease. It is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was formerly known as Regulus Therapeutics LLC and changed its name to Regulus Therapeutics Inc. in January 2009. The company was incorporated in 2007 and is based in San Diego, California. As of June 25, 2025, Regulus Therapeutics Inc. operates as a subsidiary of Novartis AG.

Address:

4224 Campus Point Court, San Diego, CA, United States, 92121

Directors & Officers

Name Title Year Born
Mr. Joseph P. Hagan M.B.A. CEO & Director 1969
Dr. Preston S. Klassen M.D., M.H.S. President, Head of Research & Development and Director 1969
Ms. Crispina Calsada CPA Chief Financial Officer 1970
Mr. Daniel J. Penksa VP of Finance & Controller 1986
Mr. Christopher Ray Aker J.D. Senior VP, General Counsel & Corporate Secretary 1961
Dr. Claire Susan Padgett M.S., M.T., Ph.D. Senior Vice President of Clinical Operations NA
Dr. Rekha Garg M.D., M.S. Chief Medical Officer NA
Mr. Edmund Lee Ph.D. Vice President of Translational Medicine NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 4.17M Mar 31, 2025 6.02% $0.00 -1.56%
Vivo Capital, LLC 2.70M Mar 31, 2025 3.89% $0.62 -46.07%
Geode Capital Management, LLC 1.30M Mar 31, 2025 1.88% $0.00 1.68%
State Street Corp 1.04M Mar 31, 2025 1.50% $0.00 -1.87%
Northern Trust Corp 444.34K Mar 31, 2025 0.64% $0.00 -2.82%
Victory Capital Management Inc. 386.67K Mar 31, 2025 0.56% $0.00 -0.83%
Wells Fargo & Co 204.31K Mar 31, 2025 0.30% $0.00 481.11%
UBS Group AG 184.89K Mar 31, 2025 0.27% $0.00 105.10%
Susquehanna International Group, LLP 150.81K Mar 31, 2025 0.22% $0.00 316.75%
Bank of New York Mellon Corp 149.36K Mar 31, 2025 0.22% $0.00 0.00%
Citadel Advisors Llc 148.28K Mar 31, 2025 0.21% $0.00 -4.68%
Renaissance Technologies Corp 147.90K Mar 31, 2025 0.21% $0.00 26.30%
Nuveen, LLC 85.60K Mar 31, 2025 0.12% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 77.62K Mar 31, 2025 0.11% $0.00 -44.47%
JPMorgan Chase & Co 74.52K Mar 31, 2025 0.11% $0.00 -60.87%
Barclays PLC 64.64K Mar 31, 2025 0.09% $0.00 -32.84%
Rhumbline Advisers 57.74K Mar 31, 2025 0.08% $0.00 -3.00%
ING Investment Management LLC 42.74K Mar 31, 2025 0.06% $0.00 85.21%
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 38.35K Mar 31, 2025 0.06% $0.00 4.48%
LPL Financial Corp 37.98K Mar 31, 2025 0.05% $0.00 -24.01%

Shares Statistics

Shares Outstanding: 69.23M
Shares Float: 57.67M
% Insiders: 270.70%
% Institutions: 8,287.40%
Short % Float: 3.23%

🏆 Top 10 Institutional Holders

Rank Holder Name Shares Held % of Shares Change Date Reported
1 BlackRock Inc 4.17M 6.02% ▼ 1.56% Mar 31, 2025
2 Vivo Capital, LLC 2.70M 3.89% ▼ 46.07% Mar 31, 2025
3 Geode Capital Management, LLC 1.30M 1.88% ▲ 1.68% Mar 31, 2025
4 State Street Corp 1.04M 1.50% ▼ 1.87% Mar 31, 2025
5 Northern Trust Corp 444.34K 0.64% ▼ 2.82% Mar 31, 2025
6 Victory Capital Management Inc. 386.67K 0.56% ▼ 0.83% Mar 31, 2025
7 Wells Fargo & Co 204.31K 0.30% ▲ 481.11% Mar 31, 2025
8 UBS Group AG 184.89K 0.27% ▲ 105.10% Mar 31, 2025
9 Susquehanna International Group, LLP 150.81K 0.22% ▲ 316.75% Mar 31, 2025
10 Bank of New York Mellon Corp 149.36K 0.22% ▲ 0.00% Mar 31, 2025

Valuation Metrics

Enterprise Value: $500.99M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $564.95M
EBITDA: $-51.40M
PEG Ratio: $-0.04
Book Value: $1.04
Earnings/Share: $-0.68
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -34.23%
ROE (TTM): -53.82%
Revenue (TTM): $5.00M
Revenue/Share (TTM): $0.07
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 27,677.80%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios (Yearly)

Financial Ratios (Quarterly)

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 10.98x 0.00x 0.09x -316.71x 0.00x
2023-12-31 3.31x 0.06x 0.31x -51.50x -0.04x
2022-12-31 3.78x 0.14x 0.29x -41.05x -0.16x
2021-12-31 12.48x 0.10x 0.20x -32.53x -0.19x
2020-12-31 3.17x 0.18x 0.31x -7.83x -0.34x
2019-12-31 1.87x 0.73x 0.52x -7.90x -0.92x
2018-12-31 0.72x -2.83x 1.21x -19.96x -0.37x
2017-12-31 2.05x 0.56x 0.55x -25.76x -0.30x
2016-12-31 6.37x 0.35x 0.44x -68.95x -0.25x
2015-12-31 11.74x 0.01x 0.12x -1,053.04x -0.02x
2014-12-31 18.96x 0.18x 0.23x -1,151.54x -0.42x
2013-12-31 21.38x 0.17x 0.24x -494.50x -0.93x
2012-12-31 7.75x 0.25x 0.40x -50.91x -0.96x
2011-12-31 3.01x -0.26x 1.97x -18.39x -1.77x
2010-12-31 3.75x 1.40x 0.87x -42.81x -0.76x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jun 03, 2025 Preston Klassen N/A Purchase 12.00K $7.99 $95.88K
Jan 30, 2025 David Baltimore N/A Purchase 19.61K $1.06 $20.79K
Jan 30, 2025 Joseph P Hagan N/A Purchase 50.00K $1.09 $54.50K
Jan 13, 2025 Christopher Ray Aker N/A Sale 38.55K $1.26 $48.57K
Jan 13, 2025 Crispina Calsada N/A Sale 38.72K $1.26 $48.78K
Jan 13, 2025 Joseph P Hagan N/A Sale 115.29K $1.26 $145.27K
Jan 13, 2025 Preston Klassen N/A Sale 31.45K $1.26 $39.62K

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about RGLS.US!